This is Auburn

 

“In simple terms, the Ebola virus compromises the body's natural immune response to its presence, and we are seeking to develop molecules to counter that effect.”

— Stewart Schneller

An Auburn University research team, led by professor of chemistry and biochemistry Stewart Schneller, has produced a new drug candidate that could one day slow or even stop the deadly Ebola virus. The group of postdoctoral associates, PhD candidates, and undergraduates designed a compound aimed at reversing the immune-blocking abilities of certain viruses, including Ebola.

This focused research and expertise represents a decade of collaboration, perseverance, and continuous improvement on results. This is WY3161, the Auburn-developed compound under extensive study in partnership with the National Institutes of Health.

Schneller directs his team in pursuing antiviral drug design and discovery with a focus on emerging and re-emerging viruses like monkeypox, measles, yellow
fever, West Nile Fever, dengue fever, and Hepatitis C.

Read the story...


Auburn helped prepare you for work and life with a solid foundation. Where has your Auburn education taken you? How has it changed you?

Share your images, stories, and posts with us by tagging @AuburnU or using the #thisisauburn hashtag. You can also email us at thisis@auburn.edu. You may be featured in our next Auburn University ad campaign.


Share This Story

 

Previous Features
Other Links

Last Updated: Oct. 27, 2014

Auburn University | Auburn, Alabama 36849 | (334) 844-9999 |
Website Feedback | Privacy | Copyright ©